# Reandron in Diabetic Men Witn Low Testosterone Level

> **NCT00613782** · PHASE2,PHASE3 · COMPLETED · sponsor: **Austin Health** · enrollment: 88 (actual)

## Conditions studied

- Type 2 Diabetes
- Hypogonadism

## Interventions

- **DRUG:** Reandron 1000
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00613782
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613782, "Reandron in Diabetic Men Witn Low Testosterone Level". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00613782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*